<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="aogs14862" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Acta Obstet Gynecol Scand</journal-id><journal-id journal-id-type="iso-abbrev">Acta Obstet Gynecol Scand</journal-id><journal-id journal-id-type="pmc-domain-id">4315</journal-id><journal-id journal-id-type="pmc-domain">aogs</journal-id><journal-id journal-id-type="publisher-id">AOGS</journal-id><journal-title-group><journal-title>Acta Obstetricia et Gynecologica Scandinavica</journal-title></journal-title-group><issn pub-type="ppub">0001-6349</issn><issn pub-type="epub">1600-0412</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11168282</article-id><article-id pub-id-type="pmcid-ver">PMC11168282.1</article-id><article-id pub-id-type="pmcaid">11168282</article-id><article-id pub-id-type="pmcaiid">11168282</article-id><article-id pub-id-type="pmid">38778571</article-id><article-id pub-id-type="doi">10.1111/aogs.14862</article-id><article-id pub-id-type="publisher-id">AOGS14862</article-id><article-id pub-id-type="other">AOGS-23-1148.R2</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Pregnancy</subject></subj-group></article-categories><title-group><article-title>Screening of substance use in pregnancy: A Danish cross&#8208;sectional study</article-title><alt-title alt-title-type="left-running-head">Rausgaard et&#160;al.</alt-title></title-group><contrib-group><contrib id="aogs14862-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Rausgaard</surname><given-names initials="NLK">Nete Lundager Klokker</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1662-3547</contrib-id><xref rid="aogs14862-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aogs14862-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>nrausgaard@health.sdu.dk</email></address></contrib><contrib id="aogs14862-cr-0002" contrib-type="author"><name name-style="western"><surname>Ibsen</surname><given-names initials="IO">Inge Olga</given-names></name><xref rid="aogs14862-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="aogs14862-cr-0003" contrib-type="author"><name name-style="western"><surname>Fruekilde</surname><given-names initials="PBN">Palle Bach Nielsen</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7274-8486</contrib-id><xref rid="aogs14862-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="aogs14862-cr-0004" contrib-type="author"><name name-style="western"><surname>Nohr</surname><given-names initials="EA">Ellen Aagaard</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7039-1105</contrib-id><xref rid="aogs14862-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aogs14862-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="aogs14862-cr-0005" contrib-type="author"><name name-style="western"><surname>Damkier</surname><given-names initials="P">Per</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0591-7187</contrib-id><xref rid="aogs14862-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aogs14862-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="aogs14862-cr-0006" contrib-type="author"><name name-style="western"><surname>Ravn</surname><given-names initials="P">Pernille</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8752-1121</contrib-id><xref rid="aogs14862-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aogs14862-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="aogs14862-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Clinical Research</named-content>
<institution>University of Southern Denmark</institution>
<city>Odense</city>
<country country="DK">Denmark</country>
</aff><aff id="aogs14862-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Gynecology and Obstetrics</named-content>
<institution>Odense University Hospital</institution>
<city>Odense</city>
<country country="DK">Denmark</country>
</aff><aff id="aogs14862-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Clinical Biochemistry</named-content>
<institution>Odense University Hospital</institution>
<city>Odense</city>
<country country="DK">Denmark</country>
</aff><aff id="aogs14862-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Clinical Pharmacology</named-content>
<institution>Odense University Hospital</institution>
<city>Odense</city>
<country country="DK">Denmark</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Nete Lundager Klokker Rausgaard, Department of Clinical Research, University of Southern Denmark, 55 Campusvej, 5230 Odense M, Denmark.<break/>
Email: <email>nrausgaard@health.sdu.dk</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>7</month><year>2024</year></pub-date><volume>103</volume><issue seq="200">7</issue><issue-id pub-id-type="pmc-issue-id">464744</issue-id><issue-id pub-id-type="doi">10.1111/aogs.v103.7</issue-id><fpage>1408</fpage><lpage>1419</lpage><history><date date-type="rev-recd"><day>29</day><month>3</month><year>2024</year></date><date date-type="received"><day>20</day><month>12</month><year>2023</year></date><date date-type="accepted"><day>15</day><month>4</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>22</day><month>05</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>13</day><month>06</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-13 10:25:14.027"><day>13</day><month>06</month><year>2024</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2024 The Authors. <italic toggle="yes">Acta Obstetricia et Gynecologica Scandinavica</italic> published by John Wiley &amp; Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="AOGS-103-1408.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:AOGS-103-1408.pdf"/><abstract><title>Abstract</title><sec id="aogs14862-sec-0001"><title>Introduction</title><p>There is a paucity of objectively verified data on substance use among Danish pregnant women. We estimated the prevalence of substance use including alcohol and nicotine among the general population of Danish pregnant women.</p></sec><sec id="aogs14862-sec-0002"><title>Material and Methods</title><p>In this anonymous, national, cross&#8208;sectional, descriptive study, pregnant women were invited when attending an ultrasound scan between November 2019 and December 2020 at nine Danish hospitals. Women submitted a urine sample and filled out a questionnaire. Urine samples were screened on&#8208;site with a qualitative urine dipstick for 15 substances including alcohol, nicotine, opioids, amphetamines, cannabis, and benzodiazepines. All screen&#8208;positive urine samples underwent secondary quantitative analyses with gold standard, liquid chromatography&#8208;tandem mass spectrometry (LC&#8211;MS/MS) analysis. Results were compared to questionnaire information to analyze the validity of self&#8208;reporting and to examine possible cross&#8208;reactions.</p></sec><sec id="aogs14862-sec-0003"><title>Results</title><p>A total of 1903 of 2154 invited pregnant women participated (88.3%). The prevalence of dipstick&#8208;positive urine samples was 25.0%. 44.0% of these were confirmed positive, resulting in a total confirmed prevalence of 10.8%. The prevalence of nicotine use was 10.1%&#8212;and for all other substances, &lt;0.5%. Nicotine use was more prevalent among younger pregnant women, while other substance use appeared evenly distributed over age groups. Self&#8208;reporting of use of nicotine products was high (71.1%), but low for cannabis and alcohol intake (0% and 33.3%, respectively). Prescription medication explained almost all cases of oxycodone, methylphenidate, and benzodiazepine use.</p></sec><sec id="aogs14862-sec-0004"><title>Conclusions</title><p>Substance use among pregnant women consisted mainly of nicotine. Dipstick screening involved risks of false negatives and false positives. Except for alcohol intake and cannabis use, dipstick analyses did not seem to provide further information than self&#8208;reporting. LC&#8211;MS/MS analyses remain gold standard, and future role of dipstick screenings should be discussed.</p></sec></abstract><abstract abstract-type="graphical"><p>Pregnant women were invited to participate in Danish hospitals from November 2019 to December 2020. Women submitted a urine sample and filled out a questionnaire. Urine samples were tested on&#8208;site with a qualitative urine dipstick for 15 different substances. All screen&#8208;positive urine samples underwent secondary quantitative analyses with gold standard, liquid chromatography&#8208;tandem mass spectrometry analysis. Results were prevalences of use of different substances, validity of dipstick analyses, and validity of self&#8208;reporting.<boxed-text position="anchor" content-type="graphic" id="aogs14862-blkfxd-0001" orientation="portrait"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="AOGS-103-1408-g001.jpg"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="aogs14862-kwd-0001">alcohol</kwd><kwd id="aogs14862-kwd-0002">cannabis</kwd><kwd id="aogs14862-kwd-0003">high risk pregnancy</kwd><kwd id="aogs14862-kwd-0004">maternal&#8211;fetal medicine</kwd><kwd id="aogs14862-kwd-0005">maternity care</kwd><kwd id="aogs14862-kwd-0006">neonatology</kwd><kwd id="aogs14862-kwd-0007">pregnancy</kwd><kwd id="aogs14862-kwd-0008">prenatal care</kwd><kwd id="aogs14862-kwd-0009">substance use</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>A.P. M&#248;ller and Chastine Mc&#8208;Kinney M&#248;ller Foundation</funding-source><award-id>19&#8208;L&#8208;0152</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Helsefonden
</institution><institution-id institution-id-type="doi">10.13039/501100005860</institution-id></institution-wrap></funding-source><award-id>20&#8208;B&#8208;0294</award-id></award-group><award-group id="funding-0003"><funding-source>Odense University Hospital PhD Committee</funding-source><award-id>A&#8208;1253</award-id><award-id>A&#8208;3616</award-id></award-group><award-group id="funding-0004"><funding-source><institution-wrap><institution>TrygFonden
</institution><institution-id institution-id-type="doi">10.13039/501100007437</institution-id></institution-wrap></funding-source><award-id>118768</award-id></award-group><award-group id="funding-0005"><funding-source>Danish Regions</funding-source><award-id>A2620</award-id></award-group></funding-group><counts><fig-count count="7"/><table-count count="2"/><page-count count="12"/><word-count count="6400"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>July 2024</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.4.4 mode:remove_FC converted:12.06.2024</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="AOGS14862-cit-2001"><string-name name-style="western"><surname>Rausgaard</surname><given-names>NLK</given-names></string-name>, <string-name name-style="western"><surname>Ibsen</surname><given-names>IO</given-names></string-name>, <string-name name-style="western"><surname>Fruekilde</surname><given-names>PBN</given-names></string-name>, <string-name name-style="western"><surname>Nohr</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Damkier</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Ravn</surname><given-names>P</given-names></string-name>. <article-title>Screening of substance use in pregnancy: A Danish cross&#8208;sectional study</article-title>. <source>Acta Obstet Gynecol Scand</source>. <year>2024</year>;<volume>103</volume>:<fpage>1408</fpage>&#8208;<lpage>1419</lpage>. doi:<pub-id pub-id-type="doi">10.1111/aogs.14862</pub-id><pub-id pub-id-type="pmcid">PMC11168282</pub-id><pub-id pub-id-type="pmid">38778571</pub-id></mixed-citation>
</p></notes></front><body id="aogs14862-body-0001"><def-list list-content="abbreviations" id="aogs14862-dl-0001"><title>Abbreviations</title><def-item><term id="aogs14862-li-0001">EtG</term><def id="aogs14862-li-0002"><p>ethyl glucuronide</p></def></def-item><def-item><term id="aogs14862-li-0003">LC&#8211;MS/MS</term><def id="aogs14862-li-0004"><p>liquid chromatography&#8208;tandem mass spectrometry</p></def></def-item></def-list><p>
<boxed-text position="anchor" content-type="box" id="aogs14862-blkfxd-0002" orientation="portrait"><caption><title>Key message</title></caption><p>Our nationwide urine screening with dipstick and confirmatory analysis found no unexpected results, suggesting our current antenatal approach with self&#8208;reporting for identifying substance use in pregnancy is adequate. However, the dipstick used may be unreliable, necessitating confirmatory analyses.</p></boxed-text>
</p><sec id="aogs14862-sec-0007"><label>1</label><title>INTRODUCTION</title><p>Substance use during pregnancy including alcohol, nicotine, and addictive medications can adversely impact both maternal well&#8208;being and child development.<xref rid="aogs14862-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="aogs14862-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="aogs14862-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="aogs14862-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="aogs14862-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="aogs14862-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="aogs14862-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> These potential detrimental effects can be minimized or averted through timely treatment and comprehensive care.<xref rid="aogs14862-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="aogs14862-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>, <xref rid="aogs14862-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> The extent of objectively measured substance use during pregnancy remains poorly documented in Denmark.</p><p>In Denmark, identification of substance use in pregnancy relies on self&#8208;reporting and on urine testing, if use is suspected. Such urine testing requires consent from the individual. Pregnant women who voluntarily disclose their substance use are offered specialized care available at local Family Outpatient Care Clinics. However, women who choose not to self&#8208;report substance use are generally less inclined to seek help.<xref rid="aogs14862-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>
</p><p>In 2017, 1.149 pregnant Danish women were registered as receiving treatment for drug and/or alcohol use which were considered a minimum<xref rid="aogs14862-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> and equivalent to 1.9% of the birth rate (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.dst.dk" ext-link-type="uri">www.dst.dk</ext-link>). A&#160;Danish government report from 2015 estimated that 3.500 pregnant women per year used alcohol and/or drugs (not nicotine/tobacco)<xref rid="aogs14862-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> equivalent to 6.0% exposed liveborn children (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.dst.dk" ext-link-type="uri">www.dst.dk</ext-link>). Recent data from the United States government suggest that approximately 8%&#8211;11% of pregnant women aged 15&#8211;44 recently used illicit substances, tobacco products, or alcohol.<xref rid="aogs14862-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> Cannabis emerged as the most prevalent illicit substance.</p><p>In our efforts to improve the identification and documentation of substance use, we proposed the integration of dipstick screening and confirmatory analyses. Dipsticks provide an easy, rapid, and cost&#8208;efficient approach for the initial screening of diverse substances.<xref rid="aogs14862-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="aogs14862-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Confirmatory analyses are imperative to validate the results obtained from the dipstick analyses.</p><p>The aims of this study were to (1) describe the distribution of use of different substances in pregnancy in a Danish cross&#8208;sectional setting, (2) evaluate the validity of a screening dipstick against confirmatory liquid chromatography&#8208;tandem mass spectrometry (LC&#8211;MS/MS) analyses, and (3) evaluate the validity of self&#8208;reported substance use.</p></sec><sec sec-type="materials-and-methods" id="aogs14862-sec-0008"><label>2</label><title>MATERIAL AND METHODS</title><p>A nationwide cross&#8208;sectional study was conducted in Denmark at intervals between November 2019 and December 2020. Screening intervals were determined randomly while accounting for practical, logistical considerations like personnel availability and department scheduling. The screening was conducted in nine hospital antenatal clinics across Denmark (Hvidovre, Bornholm, Esbjerg, Kolding, Odense, Herning, Aalborg, Slagelse, and Roskilde). The cities were chosen to encompass both small and large cities with catchment areas of different sizes representing all regions of Denmark.</p><p>To achieve a proportional representation of pregnant women, we employed a weighting technique based on the birth rates of the cities and catchment areas. Catchment areas with higher birth rates were assigned accordingly greater weights, signifying their increased significance in the overall number of births. Within each catchment area, the allocation of the target number was distributed among selected cities using the same weighting technique. Inclusion of pregnant women continued until we reached a minimum of 95% of the target number for each city.</p><p>All pregnant women attending a routine ultrasound scan were invited. In Denmark, pregnant women are offered two prenatal ultrasound scans between the 11th and 13th and the 18th and 20th weeks of gestation. The study was conducted anonymously to encourage individuals to participate without concern for privacy and to ensure a high participation rate. Those who confirmed their pregnancy status by responding positively to the question &#8220;Are you pregnant and here for a scan?&#8221; were invited to take part in the study.</p><p>The pregnant women provided a urine sample and completed a brief questionnaire. To maintain participant confidentiality, a non&#8208;identifiable numbering system was used to link the urine samples and questionnaires.</p><p>The included pregnant women self&#8208;reported various information, including age, gestational age, and medication use (prescribed, over&#8208;the&#8208;counter, vitamins, herbal remedies, and dietary supplements) within the last 7&#8201;days, as well as nicotine/tobacco product use, alcohol intake, and other substance use within the last 7&#8201;days. The questionnaire for self&#8208;reporting was designed to be brief and straightforward, aiming to encourage participation among pregnant women.</p><p>We conducted an immediate dropout analysis when pregnant women declined participation. We queried them about their age and reason for not participating, which included eight possible predefined reasons.</p><p>Medical doctors and project nurses, who were dedicated solely to this study, carried out the recruitment process without interfering with the existing healthcare dynamics. The collection of urine samples was conducted in addition to routine examinations. Some pregnant women had already provided urine samples for routine testing, resulting in missed opportunities for their participation in our study. In R&#248;nne, logistical constraints led us to involve the medical doctor who managed all routine scans on pregnant women to collect urine samples for our study. Consequently, the few samples from R&#248;nne were not collected anonymously.</p><p>Urine samples were screened on&#8208;site using a urine dipstick created for the purpose (Ferle ApS, Helleb&#230;k, Denmark). The dipstick screened for ethyl glucuronide (EtG, alcohol metabolite), cotinine (nicotine), benzodiazepines (several different benzodiazepines, calibrated for the head metabolite of clonazepam), ritalinic acid (marker for methylphenidate) and methylphenidate itself, amphetamine, methamphetamine, benzoylecgonine (marker for cocaine), pregabalin, opiates (several different opioids, calibrated for morphine), tramadol, oxycodone, methadone, buprenorphine, fentanyl, and carboxytetrahydrocannabinol (THC&#8208;COOH, marker for cannabis). The dipstick is an immunochromatographic test that enables fast detection of substances and/or their metabolites. Cut&#8208;offs and specific substances screened for are listed in Table&#160;<xref rid="aogs14862-supitem-0001" ref-type="supplementary-material">S1</xref>.</p><p>Dipstick results were considered positive if no line was visible, or negative if a line was visible in the test view area. Analyses of the dipstick results were conducted blinded for questionnaire information. All screening&#8208;negative urine samples were discarded instantly. At the screening site, dipstick&#8208;positive urine samples were immediately stored in a container with dry ice before being transferred to a &#8722;80&#176;C freezer for preservation the same day. The samples underwent confirmatory LC&#8211;MS/MS analyses. All dipstick&#8208;positive samples were analyzed for the entire range of substances included in the panel.</p><p>The confirmation analyses were conducted blinded to questionnaire information and dipstick results by an in&#8208;house isotope dilution LC&#8211;MS/MS methods at Odense University Hospital, Clinical Biochemistry. All samples were controlled for integrity by urine creatinine, and prior to LC&#8211;MS/MS analysis, all samples were subjected to de&#8208;glycosylation by hydrolysis by sodium hydroxide except for EtG. Multiplex benzodiazepines were in one separate run, likewise cannabis (THC&#8208;COOH) and EtG. All other substances were analyzed in one multiplex LC&#8211;MS/MS assay. In total, four different LC&#8211;MS/MS assays for the best overall performance.</p><sec id="aogs14862-sec-0009"><label>2.1</label><title>Statistical analyses</title><p>Study data were collected and managed using REDCap (Research Electronic Data Capture) tools hosted at Odense University Hospital, Region of Southern Denmark.<xref rid="aogs14862-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> STATA 18 was used for data merging and analysis.</p><p>The analyses were conducted using a descriptive approach. Primary objectives were to summarize prevalence rates of substance use within the study population.</p><p>When analyzing confirmation rates, same cut&#8208;offs as the dipsticks were applied for the LC&#8211;MS/MS analyses. There is no consensus on recommended cut&#8208;offs for screening during pregnancy.<xref rid="aogs14862-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> We performed subanalyses using lower and well&#8208;established cut&#8208;offs for LC&#8211;MS/MS analyses (Table&#160;<xref rid="aogs14862-supitem-0001" ref-type="supplementary-material">S1</xref>).<xref rid="aogs14862-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>
</p><p>Questionnaire data were used to evaluate the validity of self&#8208;reporting in terms of comparing use of nicotine /tobacco products, alcohol intake, and substance use with findings from the urine analyses. Questionnaire data were also examined to identify any prescribed medications, vitamins, or over&#8208;the&#8208;counter products that could be the cause of confirmed positive results or be the cause of any false&#8208;positive results due to cross&#8208;reactions. Possible cross&#8208;reactants were identified through the manufacturer&#8208;updated webpage (Ferle ApS, Helleb&#230;k, Denmark).<xref rid="aogs14862-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>
</p></sec></sec><sec sec-type="results" id="aogs14862-sec-0010"><label>3</label><title>RESULTS</title><p>A total of 1903 of the 2154 invited pregnant women participated in the study (88.3%) (Figure&#160;<xref rid="aogs14862-fig-0001" ref-type="fig">1</xref>). Among them, 1851 provided a urine sample (97.3%) and the latter 2.7% completed the questionnaire but did not provide a urine sample. The participation rate differed across hospitals from 85.4% to 92.6%.</p><fig position="float" fig-type="FIGURE" id="aogs14862-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Inclusion of participants. Inclusion of participants across the five regions of Denmark.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="AOGS-103-1408-g002.jpg"/></fig><p>A total of 462 screened positive on the dipstick corresponding to a dipstick prevalence of 25.0% (Table&#160;<xref rid="aogs14862-tbl-0001" ref-type="table">1</xref>). The number of substances detected ranged from 1 to 6 substances per urine sample. Of dipstick&#8208;positive urine samples, 198 were confirmed positive by LC&#8211;MS/MS analyses (44.0%) corresponding to a confirmed prevalence of 10.8% (Table&#160;<xref rid="aogs14862-tbl-0001" ref-type="table">1</xref>). Among confirmed positive results, cotinine was the most prevalent with a prevalence of 10.1%. The remaining substances had confirmed positive prevalences below 0.5%.</p><table-wrap position="float" id="aogs14862-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Types of substances.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" rowspan="2" valign="bottom" colspan="1"/><th align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" rowspan="2" valign="bottom" colspan="1">Dipstick positive (<italic toggle="yes">N</italic>=)</th><th align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" rowspan="2" valign="bottom" colspan="1">% of all dipstick positive (<italic toggle="yes">N</italic>&#8201;=&#8201;607)</th><th align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" rowspan="2" valign="bottom" colspan="1">Prevalence of dipstick positive of all included (<italic toggle="yes">N</italic>&#8201;=&#8201;1851)</th><th align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" rowspan="2" valign="bottom" colspan="1">LC&#8208;MS/MS positive (<italic toggle="yes">N</italic>=)</th><th align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" rowspan="2" valign="bottom" colspan="1">% of all LC&#8208;MS/MS positive (<italic toggle="yes">N</italic>&#8201;=&#8201;212)</th><th align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" rowspan="2" valign="bottom" colspan="1">Confirmation rate (%) both dipstick positive and LC&#8208;MS/MS positive for same substance</th><th align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" rowspan="2" valign="bottom" colspan="1">Prevalence of confirmed positive of all included (<italic toggle="yes">N</italic>&#8201;=&#8201;1851)</th><th align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" colspan="3" valign="bottom" rowspan="1">Subanalysis</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" style="border-right:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">LC&#8208;MS/MS positive (<italic toggle="yes">N</italic>=)</th><th align="left" style="border-right:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">% of all LC&#8208;MS/MS positive (<italic toggle="yes">N</italic>&#8201;=&#8201;274)</th><th align="left" style="border-right:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Prevalence of confirmed positive of all included (<italic toggle="yes">N</italic>&#8201;=&#8201;1851)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Total urine samples<xref rid="aogs14862-note-0201" ref-type="table-fn">*</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1851</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">450</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">450</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Negative urine samples, in total</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1389</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">252</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">195</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Positive urine samples, in total</td><td align="char" char="." valign="top" rowspan="1" colspan="1">462</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">25.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">198</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">44.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">10.8</td><td align="char" char="." valign="top" rowspan="1" colspan="1">255</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">13.9</td></tr><tr><td align="left" colspan="11" valign="top" rowspan="1">Stratified by number of positive substances per urine sample, in total<xref rid="aogs14862-note-0202" ref-type="table-fn">**</xref>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">273</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">14.7</td><td align="char" char="." valign="top" rowspan="1" colspan="1">184</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">40.9</td><td align="char" char="." valign="top" rowspan="1" colspan="1">10.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">236</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">12.8</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">107</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">5.8</td><td align="char" char="." valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">3.1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.8</td><td align="char" char="." valign="top" rowspan="1" colspan="1">19</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1.2</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">50</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">2.7</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">23</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">1.2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">0.3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">6</td><td align="char" char="." valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">0.2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" colspan="11" valign="top" rowspan="1">
<italic toggle="yes">Positive results, by substance</italic>
<xref rid="aogs14862-note-0202" ref-type="table-fn">**</xref>
</td></tr><tr><td align="left" colspan="11" valign="top" rowspan="1">Dipstick</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cotinine</td><td align="char" char="." valign="top" rowspan="1" colspan="1">248</td><td align="char" char="." valign="top" rowspan="1" colspan="1">40.9</td><td align="char" char="." valign="top" rowspan="1" colspan="1">13.4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">187</td><td align="char" char="." valign="top" rowspan="1" colspan="1">88.2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">76.6</td><td align="char" char="." valign="top" rowspan="1" colspan="1">10.1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">224</td><td align="char" char="." valign="top" rowspan="1" colspan="1">81.8</td><td align="char" char="." valign="top" rowspan="1" colspan="1">12.1</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">EtG</td><td align="char" char="." valign="top" rowspan="1" colspan="1">81</td><td align="char" char="." valign="top" rowspan="1" colspan="1">13.3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">4.4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">6</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2.8</td><td align="char" char="." valign="top" rowspan="1" colspan="1">7.6</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">23</td><td align="char" char="." valign="top" rowspan="1" colspan="1">8.4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.2</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Opiates</td><td align="char" char="." valign="top" rowspan="1" colspan="1">26</td><td align="char" char="." valign="top" rowspan="1" colspan="1">4.3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Fentanyl</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Buprenorphine</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&#8208;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&#8208;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&#8208;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&#8208;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&#8208;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&#8208;</td><td align="char" char="." valign="top" rowspan="1" colspan="1">&#8208;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Methadone</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Oxycodone</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">100.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Tramadol</td><td align="char" char="." valign="top" rowspan="1" colspan="1">9</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">11.1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cocaine</td><td align="char" char="." valign="top" rowspan="1" colspan="1">6</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">16.7</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Methamphetamine</td><td align="char" char="." valign="top" rowspan="1" colspan="1">8</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Amphetamine</td><td align="char" char="." valign="top" rowspan="1" colspan="1">40</td><td align="char" char="." valign="top" rowspan="1" colspan="1">6.6</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2.2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2.7</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Methylphenidate</td><td align="char" char="." valign="top" rowspan="1" colspan="1">62</td><td align="char" char="." valign="top" rowspan="1" colspan="1">10.2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3.4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2.4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">8.3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.8</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.3</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Pregabalin</td><td align="char" char="." valign="top" rowspan="1" colspan="1">105</td><td align="char" char="." valign="top" rowspan="1" colspan="1">17.3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">5.7</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">THC&#8208;COOH</td><td align="char" char="." valign="top" rowspan="1" colspan="1">17</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2.8</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.9</td><td align="char" char="." valign="top" rowspan="1" colspan="1">8</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3.8</td><td align="char" char="." valign="top" rowspan="1" colspan="1">47.1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">14</td><td align="char" char="." valign="top" rowspan="1" colspan="1">5.1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.8</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Benzodiazepines</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">50.0</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.7</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.1</td></tr></tbody></table><table-wrap-foot id="aogs14862-ntgp-0001"><fn id="aogs14862-note-0101"><p>
<italic toggle="yes">Note:</italic> The confirmation rate specifically examines whether the same urine sample was confirmed positive by LC&#8208;MC/MS&#8208;analysis for the same substance that the dipstick found positive. Same cut&#8208;offs were applied for both dipstick and LC&#8208;MC/MS&#8208;analysis. The subanalysis analyzed the dipstick positive cases with lower LC&#8208;MC/MS&#8208;cut&#8208;offs&#8212;cut&#8208;offs which are generally applied in the laboratory (see Table&#160;<xref rid="aogs14862-supitem-0001" ref-type="supplementary-material">S1</xref>). The total results are shown at the top, while the specific results for individual substances are shown below.</p></fn><fn id="aogs14862-note-0001"><p>Abbreviations: EtG, ethyl glucuronide; LC&#8211;MS/MS, liquid chromatography&#8208;tandem mass spectrometry.</p></fn><fn id="aogs14862-note-0201"><label>*</label><p>Twelve of the 462 dipstick positive urine samples were not included in the confirmation calculations due to U&#8208;creatinine below 2.0 mmol/L or sparse urine amount.</p></fn><fn id="aogs14862-note-0202"><label>**</label><p>Data do not sum up as one woman could have multiple positive results for different substances.</p></fn></table-wrap-foot></table-wrap><p>The confirmation rates varied significantly across substance types (0%&#8211;100%) (Table&#160;<xref rid="aogs14862-tbl-0001" ref-type="table">1</xref> and Figure&#160;<xref rid="aogs14862-fig-0002" ref-type="fig">2</xref>). Cotinine had a confirmation rate of 76.6%, EtG of 7.6%, opiates of 0%, amphetamine of 2.7%, and cannabis of 47.1%.</p><fig position="float" fig-type="FIGURE" id="aogs14862-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Validity of dipsticks. This graph provides a visual representation of relative percentages in relation to all dipstick&#8208;positive samples (<italic toggle="yes">N</italic>=) for rates of confirmation and rates of self&#8208;reported use of medications that can cause a false&#8208;positive result (=cross&#8208;react) on the dipstick based on an up&#8208;to&#8208;date list from the producer Ferle ApS (including self&#8208;reported use of prescribed medications, vitamins/herbal remedies/dietary supplements, and over&#8208;the&#8208;counter).<xref rid="aogs14862-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>
</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="AOGS-103-1408-g005.jpg"/></fig><p>Fourteen urine samples indicated potential dilution (of unknown reason) with U&#8208;creatinine levels below 2&#8201;mmol/L. Among these, seven urine samples had high LC&#8211;MS/MS concentrations and remained classified as confirmed positive. The remaining seven urine samples had LC&#8211;MS/MS concentrations significantly below the cut&#8208;offs and were omitted from the analyses.</p><p>Age of all included pregnant women were normally distributed, with a mean of 30.4 (min 17; max 55) (data not shown). Mean gestational age of all included pregnant women was 23.3 (min 5; max&#160;42).</p><p>Mean age among non&#8208;participants was 30.5. Of the non&#8208;participants, 67% opted out without giving explicit reasons, 11% mentioned difficulty urinating, 9% struggled with language comprehension, 6% were constrained by time, and remaining reasons included feelings of sadness after the scan, nervousness, and a perceived lack of study relevance.</p><p>Substance use was found to be higher among younger pregnant women (Table&#160;<xref rid="aogs14862-tbl-0001" ref-type="table">1</xref>). Upon stratifying for cotinine use, only cotinine use was concentrated among the younger age groups, while other substance use was consistent across age groups (Figure&#160;<xref rid="aogs14862-fig-0003" ref-type="fig">3</xref>). Use of substances remained relatively stable throughout the entire pregnancy period, and stratifying for cotinine use showed no difference (Figure&#160;<xref rid="aogs14862-fig-0004" ref-type="fig">4</xref>).</p><fig position="float" fig-type="FIGURE" id="aogs14862-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>Age and Confirmed Positive Samples. This visualization allows for a comparison of substance use patterns among pregnant women at different ages, stratified by confirmed cotinine use. Each individual blue dot represents a pregnant woman when age is given. In the graph, a red smoothing line descriptively shows the relation between age and the probability of a positive test. The left graph shows the age distribution of pregnant women with confirmed vs not confirmed positive cotinine samples, indicating tobacco/nicotine product use. The right graph shows the age distribution of pregnant women with confirmed vs not confirmed positive samples for substances other than cotinine.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="AOGS-103-1408-g004.jpg"/></fig><fig position="float" fig-type="FIGURE" id="aogs14862-fig-0004" orientation="portrait"><label>FIGURE 4</label><caption><p>Gestational Age and Confirmed Positive Samples. This visualization allows for a comparison of substance use patterns at different stages of pregnancy, stratified by cotinine use. Each individual blue dot represents a pregnant woman when age is given. In the graph, a red smoothing line descriptively shows the relation between gestational age and the probability of a positive test. The graph on the left shows the gestational age distribution of pregnant women with confirmed vs not confirmed positive cotinine samples, indicating tobacco/nicotine product use. The right graph shows the gestational age distribution of pregnant women with confirmed vs not confirmed positive samples for substances other than cotinine.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="AOGS-103-1408-g007.jpg"/></fig><p>Distinct patterns emerged when analyzing the data across different cities, with prevalences ranging from 7.2% to 20.9% (Table&#160;<xref rid="aogs14862-tbl-0002" ref-type="table">2</xref>; Figure&#160;<xref rid="aogs14862-fig-0005" ref-type="fig">5</xref>).</p><table-wrap position="float" id="aogs14862-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Self&#8208;reported characteristics of pregnant women.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" rowspan="2" valign="bottom" colspan="1"/><th align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Negative</th><th align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" colspan="2" valign="bottom" rowspan="1">Positive</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" style="border-right:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">(<italic toggle="yes">N</italic>=)</th><th align="left" style="border-right:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">(<italic toggle="yes">N</italic>=)</th><th align="left" style="border-right:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">(%)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="char" char="." valign="top" rowspan="1" colspan="1">1641</td><td align="char" char="." valign="top" rowspan="1" colspan="1">198</td><td align="char" char="." valign="top" rowspan="1" colspan="1">10.8</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">Maternal age group (years)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">&lt;19</td><td align="char" char="." valign="top" rowspan="1" colspan="1">10</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">23.1</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">20&#8211;24</td><td align="char" char="." valign="top" rowspan="1" colspan="1">118</td><td align="char" char="." valign="top" rowspan="1" colspan="1">32</td><td align="char" char="." valign="top" rowspan="1" colspan="1">21.3</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">25&#8211;29</td><td align="char" char="." valign="top" rowspan="1" colspan="1">565</td><td align="char" char="." valign="top" rowspan="1" colspan="1">70</td><td align="char" char="." valign="top" rowspan="1" colspan="1">11.0</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">30&#8211;34</td><td align="char" char="." valign="top" rowspan="1" colspan="1">616</td><td align="char" char="." valign="top" rowspan="1" colspan="1">55</td><td align="char" char="." valign="top" rowspan="1" colspan="1">8.2</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">35&#8211;39</td><td align="char" char="." valign="top" rowspan="1" colspan="1">245</td><td align="char" char="." valign="top" rowspan="1" colspan="1">30</td><td align="char" char="." valign="top" rowspan="1" colspan="1">10.9</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">&gt;40</td><td align="char" char="." valign="top" rowspan="1" colspan="1">69</td><td align="char" char="." valign="top" rowspan="1" colspan="1">5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">6.8</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">Gestational age group (weeks)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">&lt;14</td><td align="char" char="." valign="top" rowspan="1" colspan="1">463</td><td align="char" char="." valign="top" rowspan="1" colspan="1">59</td><td align="char" char="." valign="top" rowspan="1" colspan="1">11.3</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">15&#8211;19</td><td align="char" char="." valign="top" rowspan="1" colspan="1">69</td><td align="char" char="." valign="top" rowspan="1" colspan="1">12</td><td align="char" char="." valign="top" rowspan="1" colspan="1">14.8</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">20&#8211;24</td><td align="char" char="." valign="top" rowspan="1" colspan="1">452</td><td align="char" char="." valign="top" rowspan="1" colspan="1">38</td><td align="char" char="." valign="top" rowspan="1" colspan="1">7.8</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">25&#8211;29</td><td align="char" char="." valign="top" rowspan="1" colspan="1">138</td><td align="char" char="." valign="top" rowspan="1" colspan="1">14</td><td align="char" char="." valign="top" rowspan="1" colspan="1">9.2</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">30&#8211;34</td><td align="char" char="." valign="top" rowspan="1" colspan="1">195</td><td align="char" char="." valign="top" rowspan="1" colspan="1">33</td><td align="char" char="." valign="top" rowspan="1" colspan="1">14.5</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">35&#8211;39</td><td align="char" char="." valign="top" rowspan="1" colspan="1">243</td><td align="char" char="." valign="top" rowspan="1" colspan="1">32</td><td align="char" char="." valign="top" rowspan="1" colspan="1">11.6</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">40&#8211;44</td><td align="char" char="." valign="top" rowspan="1" colspan="1">49</td><td align="char" char="." valign="top" rowspan="1" colspan="1">5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">9.3</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">Geography</td></tr><tr><td align="left" style="padding-left:10%" colspan="4" valign="top" rowspan="1">Capitol Region of Denmark</td></tr><tr><td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Hvidovre</td><td align="char" char="." valign="top" rowspan="1" colspan="1">337</td><td align="char" char="." valign="top" rowspan="1" colspan="1">26</td><td align="char" char="." valign="top" rowspan="1" colspan="1">7.2</td></tr><tr><td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">R&#248;nne</td><td align="char" char="." valign="top" rowspan="1" colspan="1">23</td><td align="char" char="." valign="top" rowspan="1" colspan="1">3</td><td align="char" char="." valign="top" rowspan="1" colspan="1">11.5</td></tr><tr><td align="left" style="padding-left:10%" colspan="4" valign="top" rowspan="1">Region of Southern Denmark</td></tr><tr><td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Esbjerg</td><td align="char" char="." valign="top" rowspan="1" colspan="1">86</td><td align="char" char="." valign="top" rowspan="1" colspan="1">21</td><td align="char" char="." valign="top" rowspan="1" colspan="1">19.6</td></tr><tr><td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Kolding</td><td align="char" char="." valign="top" rowspan="1" colspan="1">168</td><td align="char" char="." valign="top" rowspan="1" colspan="1">19</td><td align="char" char="." valign="top" rowspan="1" colspan="1">10.2</td></tr><tr><td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Odense</td><td align="char" char="." valign="top" rowspan="1" colspan="1">254</td><td align="char" char="." valign="top" rowspan="1" colspan="1">21</td><td align="char" char="." valign="top" rowspan="1" colspan="1">7.6</td></tr><tr><td align="left" style="padding-left:10%" colspan="4" valign="top" rowspan="1">Central Denmark Region</td></tr><tr><td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Herning</td><td align="char" char="." valign="top" rowspan="1" colspan="1">249</td><td align="char" char="." valign="top" rowspan="1" colspan="1">32</td><td align="char" char="." valign="top" rowspan="1" colspan="1">11.4</td></tr><tr><td align="left" style="padding-left:10%" colspan="4" valign="top" rowspan="1">North Denmark region</td></tr><tr><td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Aalborg</td><td align="char" char="." valign="top" rowspan="1" colspan="1">230</td><td align="char" char="." valign="top" rowspan="1" colspan="1">32</td><td align="char" char="." valign="top" rowspan="1" colspan="1">12.2</td></tr><tr><td align="left" style="padding-left:10%" colspan="4" valign="top" rowspan="1">Region Zealand</td></tr><tr><td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Slagelse</td><td align="char" char="." valign="top" rowspan="1" colspan="1">110</td><td align="char" char="." valign="top" rowspan="1" colspan="1">29</td><td align="char" char="." valign="top" rowspan="1" colspan="1">20.9</td></tr><tr><td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Roskilde</td><td align="char" char="." valign="top" rowspan="1" colspan="1">184</td><td align="char" char="." valign="top" rowspan="1" colspan="1">15</td><td align="char" char="." valign="top" rowspan="1" colspan="1">7.5</td></tr></tbody></table><table-wrap-foot id="aogs14862-ntgp-0005"><fn id="aogs14862-note-0105"><p>
<italic toggle="yes">Note:</italic> The table shows observational data with distributions. Maternal age and gestational age were self&#8208;reported. &#8220;Geography&#8221;: refers to the specific city in which the pregnant women included in the study were screened for analysis. &#8220;Negative&#8221;: includes the dipstick&#8208;negative, which have not undergone LC&#8208;MC/MS&#8208;analyses, as well as the dipstick&#8208;positives that were not confirmed positive by LC&#8208;MC/MS&#8208;analyses. &#8220;Positive&#8221;: includes confirmed positive results (dipstick&#8208;positive found positive by LC&#8208;MC/MS&#8208;analyses).</p></fn></table-wrap-foot></table-wrap><fig position="float" fig-type="FIGURE" id="aogs14862-fig-0005" orientation="portrait"><label>FIGURE 5</label><caption><p>Distribution of substances across Denmark. (A) Total prevalences and prevalences of cotinine stratified by city. Please note that some urine samples were positive for two substances and both results are shown. (B) Distribution of substances among confirmed positive urine samples stratified by city (parts of whole). Please note that some urine samples were positive for two substances and both results are shown. (C) Zoom&#8208;in on the total bar showing the distribution of substances except for cotinine. Please note that some urine samples were positive for two substances and both results are shown.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-11" orientation="portrait" xlink:href="AOGS-103-1408-g006.jpg"/></fig><p>Of confirmed positive cotinine samples, 71.1% had self&#8208;reported use. Of confirmed positive EtG samples, 33.3% had self&#8208;reported alcohol intake (Figure&#160;<xref rid="aogs14862-fig-0006" ref-type="fig">6</xref>). The single confirmed positive sample for amphetamine was self&#8208;reported as non&#8208;prescribed (100%); both confirmed positive cases of oxycodone and benzodiazepines were self&#8208;reported as medication use prescribed by their doctor; and of confirmed positive methylphenidate samples, 80.0% had self&#8208;reported medication use.</p><fig position="float" fig-type="FIGURE" id="aogs14862-fig-0006" orientation="portrait"><label>FIGURE 6</label><caption><p>Validity of self&#8208;reporting. This graph provides a visual representation of the percentages in relation to all confirmed positive samples for rates of self&#8208;reported use of substances (tobacco/nicotine products, alcohol intake, and non&#8208;prescribed use of amphetamines&#8201;=&#8201;red lines) and medications (prescribed medications, vitamins/herbal remedies/dietary supplements, and over&#8208;the&#8208;counter medications&#8201;=&#8201;blue lines). Zoom&#8208;in on the substances with lower prevalences.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-13" orientation="portrait" xlink:href="AOGS-103-1408-g003.jpg"/></fig><p>A total of 171 pregnant women self&#8208;reported use of nicotine (9.0% of all included pregnant women) (data not shown). Among them, 91.2% were dipstick positive (<italic toggle="yes">n</italic>&#8201;=&#8201;156) and 77.8% were confirmed positive (<italic toggle="yes">n</italic>&#8201;=&#8201;133). Sixty&#8208;three pregnant women self&#8208;reported recent alcohol intake (3.3% of all included pregnant women). Of these, 6.3% were dipstick positive (<italic toggle="yes">n</italic>&#8201;=&#8201;4) and 3.2% were confirmed positive (<italic toggle="yes">n</italic>&#8201;=&#8201;2).</p><p>Among all dipstick&#8208;positive cases that were not confirmed, 6.4% could be due to cross&#8208;reactions, where medications caused dipstick&#8208;positive tramadol and amphetamine results (Figure&#160;<xref rid="aogs14862-fig-0002" ref-type="fig">2</xref>).</p><p>In the subanalysis, using lower cut&#8208;off levels increased the total confirmed prevalence to 13.8% due to additional findings of nicotine, EtG, opiates, cannabis, and benzodiazepines (Table&#160;<xref rid="aogs14862-tbl-0001" ref-type="table">1</xref>).</p></sec><sec sec-type="discussion" id="aogs14862-sec-0011"><label>4</label><title>DISCUSSION</title><p>In this first cross&#8208;sectional, large&#8208;scale, national urinary screening study for substance use in pregnancy, the prevalence of substance use among pregnant women was 10.8%. Almost all confirmed positive samples were attributed to nicotine use. The dipstick performed poorly, as only 44.0% of the positive results from the initial dipstick screening were confirmed. Age was not associated with refusal or substance use, except for the observation that cotinine use was more prevalent among younger pregnant women. Substance use appeared relatively stable throughout pregnancy. The evaluation of patterns of substance use across the country showed locally and clinically interesting differences, but due to the low prevalence of substances other than cotinine, significant conclusions were not meaningful. Self&#8208;reporting was generally high for nicotine, but low for alcohol and cannabis. Most methylphenidate and both oxycodone and benzodiazepines cases were explained by use of prescription medication.</p><p>Our pilot study from 2013 was confined to a specific region of Denmark but used a similar approach as in the current study and found an overall prevalence of 3.6% for substance use in pregnancy, including 0.5% due to cannabis and 3.1% due to opiates.<xref rid="aogs14862-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> When we compare our present results with those from the pilot study, the cannabis prevalence seems consistent and the opioid prevalence appears reduced. We anticipated a higher prevalence of opioids, considering not only the opioid epidemic but also the fact that our screening panel encompassed a broader range of opioids, allowing us to detect various types regardless of their indication for use (whether illegal or prescribed). A recent Danish study has found a higher prevalence of opioid use in 2.0% using registry data on filled opioid prescriptions.<xref rid="aogs14862-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> In the United Kingdom and the United States, the prevalence of opioid use has been estimated even higher at 4.0% using urine analyses,<xref rid="aogs14862-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="aogs14862-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> and in Spain at 5.7%.<xref rid="aogs14862-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>
</p><p>The Spanish study was conducted in 2011&#8211;2015 and used maternal hair, meconium, placenta, and umbilical cord. The authors furthermore found a prevalence of nicotine of 13.6%, alcohol 8.4%, cocaine 8.3%, and cannabis 6.4%.<xref rid="aogs14862-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> This approach offers a broader window of detection compared to urine analyses, potentially extending back to the first trimester.</p><p>A scoping review of 41 studies has found a prevalence of cannabis use ranging from 0.24% to 22.6%, increasing across the years 2000&#8211;2019.<xref rid="aogs14862-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> Individual studies from the United States have estimated it even higher (19%&#8211;31%) based on urine analyses.<xref rid="aogs14862-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="aogs14862-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>, <xref rid="aogs14862-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> One of these studies also found prevalences of nicotine of 17%, alcohol 19.4%, opioids 4.0%, cocaine 0.8%, amphetamines 1.2%, and benzodiazepines 1.0%.<xref rid="aogs14862-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>
</p><p>Recent Danish studies show varying alcohol prevalence estimates: 0.4% for heavy exposure,<xref rid="aogs14862-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> 3% for weekly intake,<xref rid="aogs14862-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> and up to 35% for binge drinking.<xref rid="aogs14862-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> In Sweden, a recent estimate was 4.2%,<xref rid="aogs14862-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> and in Finland, it was 7.1%.<xref rid="aogs14862-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> The relatively low alcohol prevalence in the present study (0.3%) is likely due not only to the timing and quantity of intake but also to limitations in the design of the dipstick (eg, very short window of detection and high cut&#8208;off values), and the interindividual variability in the EtG excretion.<xref rid="aogs14862-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>
</p><p>Other studies have indicated that pregnant women who use one substance (including nicotine) tend to also use others.<xref rid="aogs14862-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="aogs14862-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="aogs14862-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>, <xref rid="aogs14862-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>, <xref rid="aogs14862-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>, <xref rid="aogs14862-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>, <xref rid="aogs14862-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref>, <xref rid="aogs14862-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> We found that of 198 positive cases, 7.1% were positive for two substances (mostly nicotine and cannabis) (Table&#160;<xref rid="aogs14862-tbl-0001" ref-type="table">1</xref>).</p><p>To ensure a representative sample and avoid inclusion/selection bias, we aimed at a consecutive recruitment of pregnant women attending routine ultrasound scans, a widely attended appointment, rather than selected groups (non&#8208;routine scans or consultations). The high participation rate of 88.3% was likely due to the anonymity of the sampling. Various factors, such as stigma, fear of judgment, and concerns about anonymity, may have influenced participation rates. The mean age of the pregnant women in the study was similar to that of the general pregnant population.<xref rid="aogs14862-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> Some pregnant women attending non&#8208;routine scans may have inadvertently been included, but these cases are expected to be minimal. The self&#8208;reported data in the questionnaires may have recall bias. We occasionally assisted in completing it because some pregnant women reported being too busy or not proficient in the Danish language. This could introduce information bias.</p><p>The study was conducted during the COVID&#8208;19 pandemic, and due to hospital restrictions in Denmark, we could not include pregnant women from Aarhus (Skejby Hospital, Central Denmark Region) and one of the two included hospitals in Copenhagen (Herlev Hospital, Capitol Region of Denmark), as only limited access was granted. It would have been valuable to examine whether pregnant women from these urban areas exhibited distinct substance use patterns. In the other cities, restrictions, such as two meters of distance, protective equipment, and the fact that pregnant women were not allowed to bring partners, might have influenced the participation rate. This study did not directly assess the impact of the pandemic on substance use patterns among pregnant women. Despite the absence of comparative Danish data, a notable difference in opioid prevalence was observed compared to our pilot study from 2013.</p><p>The confirmation rate for cotinine was 76.6%, whereas the confirmation rates for EtG, opiates, amphetamine, methylphenidate, and pregabalin were unsatisfactory with high false&#8208;positive rates. The significance of confirmation rates of remaining substances could not be evaluated. Screening analyses are expected to have higher cut&#8208;offs than confirmatory analyses to reduce the risk of false&#8208;positive results caused by cross&#8208;reactions.<xref rid="aogs14862-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> In the present study, we only found a few false&#8208;positive results to be due to cross&#8208;reactions (6.4%) indicating that the cut&#8208;offs were adequately high, although it infers a tradeoff of a high rate of false negatives. This risk is underscored by the finding that 38 pregnant women self&#8208;reported recent nicotine use, yet their urine samples were not confirmed positive for cotinine. We therefore consider the total confirmed prevalence of 10.8% as a minimum estimate. This consideration is further substantiated by several other reasons: (1) When we applied widely accepted lower cut&#8208;off values on the LC&#8211;MS/MS analyses,<xref rid="aogs14862-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> the prevalence reached 13.8%. (2) We found nine additional, positive, &#8220;random&#8221; findings among samples that underwent confirmation analyses for other findings (<italic toggle="yes">data not shown</italic>). If we included these &#8220;random&#8221; findings, the total prevalence would increase from 10.8 to 11.3%. (3) The non&#8208;participating pregnant women (<italic toggle="yes">N</italic>&#8201;=&#8201;251), those who consented but did not provide a urine sample (<italic toggle="yes">N</italic>&#8201;=&#8201;52), and those who provided insufficient or diluted urine samples (<italic toggle="yes">N</italic>&#8201;=&#8201;12) hold particular significance. It is possible that some of these pregnant women might have screened positive had they fully participated in the study.</p><p>This study only provides a momentary snapshot, where a positive result indicates recent use within a timeframe of hours to days (although for certain substances associated with chronic use, detection can extend to several weeks, eg, benzodiazepines, cocaine, and cannabis).<xref rid="aogs14862-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> Specific cut&#8208;off values have been established to eliminate the possibility of a positive result due to passive exposure such as extraneous alcohol exposure or cannabis smoke inhalation.<xref rid="aogs14862-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> Notably, the dipstick has demonstrated the capability to detect intake of 1&#8211;4&#8201;units of alcohol for up to 24&#8201;h after intake.<xref rid="aogs14862-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> In the present study, distinguishing whether a confirmed positive EtG sample involved a single unit of alcohol imbibed a few hours prior or multiple units consumed a couple of days earlier remains beyond our analytical scope. Interestingly, we noted a much higher number of pregnant women who self&#8208;reported alcohol intake compared to our objective findings, but those who self&#8208;reported an intake, self&#8208;reported only 0.5&#8211;1.0 alcohol units within the last 7&#8201;days. These low levels could only reasonably explain the few positive outcomes if the consumption had occurred shortly before the collection of urine samples.<xref rid="aogs14862-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref>
</p><p>In the present study, all dipstick&#8208;negative samples were excluded from LC&#8211;MS/MS analysis. However, we expanded our analysis by conducting preliminary LC&#8211;MS/MS analyses on 282 urine samples collected at the same hospital, irrespective of dipstick results. Our preliminary findings indicate that relying solely on confirmatory analyses of dipstick&#8208;positive samples may result in missing positive cases, as demonstrated by our identification of positive substances in 4.3% of dipstick&#8208;negative samples using LC&#8211;MS/MS.</p><p>It was not possible to examine sensitivity and specificity of self&#8208;reporting against LC&#8211;MS/MS analyses since not all samples underwent LC&#8211;MS/MS analysis. However, an in&#8208;depth analysis to assess the validity of self&#8208;reporting showed varying degree of correlations (Figure&#160;<xref rid="aogs14862-fig-0006" ref-type="fig">6</xref>). Interestingly, pregnant women tended to self&#8208;report nicotine use, and not alcohol intake or cannabis use&#8212;a picture that has been described similarly previously.<xref rid="aogs14862-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> Several other studies have examined the validity of self&#8208;reported substance use among pregnant women, comparing it to different biochemical measures. While some have found self&#8208;reporting to be valuable,<xref rid="aogs14862-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>, <xref rid="aogs14862-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> others have emphasized its limitations.<xref rid="aogs14862-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="aogs14862-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>, <xref rid="aogs14862-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>, <xref rid="aogs14862-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref>, <xref rid="aogs14862-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> Self&#8208;reporting includes risk of information bias such as suppression, omission, or alteration. A recent scoping review of 12 studies concluded that self&#8208;reporting was more accurate among women with current or prior history of substance use.<xref rid="aogs14862-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> Similarly, a recent study found that pregnant women who reported alcohol use were more likely to also report cannabis use.<xref rid="aogs14862-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref>
</p><p>A recent study from the United Kingdom also found limitations in point&#8208;of&#8208;care urine drug testing and concluded that confirmation analyses may be necessary in an antenatal care setting.<xref rid="aogs14862-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> As opposed to dipstick analyses, LC&#8211;MS/MS analyses do not include risks of cross&#8208;reactivity (eg, prescribed medications), they have lower detection cut&#8208;offs, and they can distinguish between different substances within the same class, which all together increases the likelihood of identifying pregnant women with substance use and decreases the risk of falsely accusing pregnant women of substance use.</p></sec><sec sec-type="conclusions" id="aogs14862-sec-0012"><label>5</label><title>CONCLUSION</title><p>In this study, substance use among pregnant women was rare except for nicotine use. Compared to self&#8208;reporting, dipstick analyses do not significantly improve detection rates&#8212;except for alcohol and cannabis. Our findings support an emphasis on confirmatory analyses, and any dipstick&#8208;positive sample should undergo confirmation through LC&#8211;MS/MS.<xref rid="aogs14862-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> It is crucial to be aware of the high risk of dipstick false negatives, and it is essential to regard a dipstick&#8208;positive result as &#8220;potentially positive.&#8221;</p></sec><sec id="aogs14862-sec-0013"><title>AUTHOR CONTRIBUTIONS</title><p>Nete Lundager Klokker Rausgaard: Study conception and design, data collection, draft manuscript preparation, and graphical abstract figure. Inge Olga Ibsen: Study conception and design and data collection. Ellen Aagaard Nohr and Per Damkier: Study conception and design. Pernille RAVN: Study conception and design and draft manuscript preparation. All authors: Analysis and interpretation of results, critical review of the manuscript, approval of the final version, and agreement to be accountable for all aspects.</p></sec><sec id="aogs14862-sec-0015"><title>FUNDING INFORMATION</title><p>Funding for this study was provided by Trygfonden [grant number 118768], Odense University Hospital PhD Committee [A&#8208;1253 and A&#8208;3616], Danish Regions [grant number A2620], Helsefonden [grant number 20&#8208;B&#8208;0294], and A.P. M&#248;ller and Chastine Mc&#8208;Kinney M&#248;ller Foundation [grant number 19&#8208;L&#8208;0152].</p></sec><sec sec-type="COI-statement" id="aogs14862-sec-0016"><title>CONFLICT OF INTEREST STATEMENT</title><p>None.</p></sec><sec id="aogs14862-sec-0017"><title>ETHICS STATEMENT</title><p>Use of anonymized data for non&#8208;interventional research does not require approval from an Ethics Committee under Danish Law. Decisions from the Local Ethics Committee and the Regional Data Collection Agency can be e&#8208;mailed on request.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="aogs14862-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
Table&#160;S1:
</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AOGS-103-1408-s001.pdf" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="aogs14862-sec-0014"><title>ACKNOWLEDGMENTS</title><p>The present study used the datafile, REDCap (Research Electronic Data Capture), from OPEN, Open Patient Data Explorative Network, Odense University Hospital, Region of Southern Denmark. The authors wish to thank Nete B&#252;low, Winnie Hjorth, Louise Svenstrup, Karen W&#248;jdemann, Trine Lynddahl, and Michela Dalsgaard, who assisted in inclusion of pregnant women and collection of data at screening sites.</p></ack><ref-list content-type="cited-references" id="aogs14862-bibl-0001"><title>REFERENCES</title><ref id="aogs14862-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="aogs14862-cit-0002"><string-name name-style="western"><surname>Makarious</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Teng</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Oei</surname><given-names>JL</given-names></string-name>. <article-title>SIDS is associated with prenatal drug use: a meta&#8208;analysis and systematic review of 4 238 685 infants</article-title>. <source>Arch Dis Child Fetal Neonatal Ed</source>. <year>2022</year>;<volume>107</volume>:<fpage>617</fpage>&#8208;<lpage>623</lpage>.<pub-id pub-id-type="pmid">35396270</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/archdischild-2021-323260</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="aogs14862-cit-0003"><string-name name-style="western"><surname>Pereira</surname><given-names>PP</given-names></string-name>, <string-name name-style="western"><surname>Da Mata</surname><given-names>FA</given-names></string-name>, <string-name name-style="western"><surname>Figueiredo</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>de Andrade</surname><given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Pereira</surname><given-names>MG</given-names></string-name>. <article-title>Maternal active smoking during pregnancy and low birth weight in the Americas: a systematic review and meta&#8208;analysis</article-title>. <source>Nicotine Tob Res</source>. <year>2017</year>;<volume>19</volume>(<issue>5</issue>):<fpage>497</fpage>&#8208;<lpage>505</lpage>.<pub-id pub-id-type="pmid">28403455</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ntr/ntw228</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="aogs14862-cit-0004"><string-name name-style="western"><surname>Broccia</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hansen</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Winckler</surname><given-names>JM</given-names></string-name>, et&#160;al. <article-title>Heavy prenatal alcohol exposure and obstetric and birth outcomes: a Danish nationwide cohort study from 1996 to 2018</article-title>. <source>Lancet Public Health</source>. <year>2023</year>;<volume>8</volume>:<fpage>e28</fpage>&#8208;<lpage>e35</lpage>.<pub-id pub-id-type="pmid">36603908</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2468-2667(22)00263-8</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="aogs14862-cit-0005"><string-name name-style="western"><surname>Mamluk</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Edwards</surname><given-names>HB</given-names></string-name>, <string-name name-style="western"><surname>Savovi&#263;</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Low alcohol consumption and pregnancy and childhood outcomes: time to change guidelines indicating apparently &#8216;safe&#8217; levels of alcohol during pregnancy? A systematic review and meta&#8208;analyses</article-title>. <source>BMJ Open</source>. <year>2017</year>;<volume>7</volume>:<elocation-id>e015410</elocation-id>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2016-015410</pub-id><pub-id pub-id-type="pmcid">PMC5642770</pub-id><pub-id pub-id-type="pmid">28775124</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="aogs14862-cit-0006"><string-name name-style="western"><surname>Singh</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Filion</surname><given-names>KB</given-names></string-name>, <string-name name-style="western"><surname>Abenhaim</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Eisenberg</surname><given-names>MJ</given-names></string-name>. <article-title>Prevalence and outcomes of prenatal recreational cannabis use in high&#8208;income countries: a scoping review</article-title>. <source>BJOG</source>. <year>2020</year>;<volume>127</volume>:<fpage>8</fpage>&#8208;<lpage>16</lpage>.<pub-id pub-id-type="pmid">31529594</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/1471-0528.15946</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="aogs14862-cit-0007"><string-name name-style="western"><surname>Flak</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Su</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Bertrand</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Denny</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Kesmodel</surname><given-names>US</given-names></string-name>, <string-name name-style="western"><surname>Cogswell</surname><given-names>ME</given-names></string-name>. <article-title>The association of mild, moderate, and binge prenatal alcohol exposure and child neuropsychological outcomes: a meta&#8208;analysis</article-title>. <source>Alcohol Clin Exp Res</source>. <year>2014</year>;<volume>38</volume>:<fpage>214</fpage>&#8208;<lpage>226</lpage>.<pub-id pub-id-type="pmid">23905882</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/acer.12214</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="aogs14862-cit-0008"><string-name name-style="western"><surname>Popova</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lange</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Probst</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Gmel</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Rehm</surname><given-names>J</given-names></string-name>. <article-title>Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta&#8208;analysis</article-title>. <source>Lancet Glob Health</source>. <year>2017</year>;<volume>5</volume>:<fpage>e290</fpage>&#8208;<lpage>e299</lpage>.<pub-id pub-id-type="pmid">28089487</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2214-109X(17)30021-9</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="aogs14862-cit-0009"><string-name name-style="western"><surname>Hjerkinn</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Rosvold</surname><given-names>EO</given-names></string-name>, <string-name name-style="western"><surname>Lindbaek</surname><given-names>M</given-names></string-name>. <article-title>Neonatal findings among children of substance&#8208;abusing women attending a special child welfare clinic in Norway</article-title>. <source>Scand J Public Health</source>. <year>2009</year>;<volume>37</volume>:<fpage>751</fpage>&#8208;<lpage>757</lpage>.<pub-id pub-id-type="pmid">19622548</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1403494809342310</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="aogs14862-cit-0010"><string-name name-style="western"><surname>Boden</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Jones</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Cabacungan</surname><given-names>ET</given-names></string-name>. <article-title>Improved maternal and infant outcomes with serial, self&#8208;reported early prenatal substance use screening</article-title>. <source>Matern Child Health J</source>. <year>2021</year>;<volume>25</volume>:<fpage>1118</fpage>&#8208;<lpage>1125</lpage>.<pub-id pub-id-type="pmid">33904025</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10995-021-03127-1</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="aogs14862-cit-0011"><string-name name-style="western"><surname>Vella</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Savona&#8208;Ventura</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Mahmood</surname><given-names>T</given-names></string-name>. <article-title>Harmful effects of opioid use in pregnancy: a scientific review commissioned by the European Board and college of obstetrics and gynaecology (EBCOG)</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source>. <year>2023</year>;<volume>286</volume>:<fpage>70</fpage>&#8208;<lpage>75</lpage>.<pub-id pub-id-type="pmid">37216740</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejogrb.2023.05.019</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="aogs14862-cit-0012"><string-name name-style="western"><surname>Berra</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kamo</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mohnot</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>The association between antenatal maternal self&#8208;reported substance use, maternal characteristics, and obstetrical variables</article-title>. <source>J Addict Med</source>. <year>2019</year>;<volume>13</volume>:<fpage>464</fpage>&#8208;<lpage>469</lpage>.<pub-id pub-id-type="pmid">31033670</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ADM.0000000000000521</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0012"><label>12</label><mixed-citation publication-type="miscellaneous" id="aogs14862-cit-0013"><collab collab-type="authors">Socialstyrelsen [National Board of Health and Welfare]</collab>
. <article-title>Udsatte gravide med skadeligt rusmiddelforbrug [Vulnerable pregnant women with harmful substance abuse]</article-title>. <year>2022</year>.</mixed-citation></ref><ref id="aogs14862-bib-0013"><label>13</label><mixed-citation publication-type="miscellaneous" id="aogs14862-cit-0014"><article-title>Social&#8208;og Indenrigsministeriet, Sundheds&#8208;og &#198;ldreministeriet [The Ministry of Social Affairs H, and Senior Citizens]. Arbejdsgruppe om gravide med et forbrug og misbrug af rusmidler [Working group on pregnant women with substance use and abuse]</article-title>. <year>2015</year>.</mixed-citation></ref><ref id="aogs14862-bib-0014"><label>14</label><mixed-citation publication-type="miscellaneous" id="aogs14862-cit-0015"><collab collab-type="authors">Substance Abuse and Mental Health Services Administration</collab>
. <article-title>National survey on drug use and health: women</article-title>. <year>2020</year>. US Department of Health and Human Services.</mixed-citation></ref><ref id="aogs14862-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="aogs14862-cit-0016"><string-name name-style="western"><surname>Kroska</surname><given-names>EB</given-names></string-name>, <string-name name-style="western"><surname>Meller</surname><given-names>EW</given-names></string-name>, <string-name name-style="western"><surname>Doyle</surname><given-names>R</given-names></string-name>, et&#160;al. <article-title>Drug screening during pregnancy: urine dip cups measure up</article-title>. <source>Drug Alcohol Depend</source>. <year>2019</year>;<volume>204</volume>:<elocation-id>107461</elocation-id>.<pub-id pub-id-type="pmid">31521952</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2019.04.032</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="aogs14862-cit-0017"><string-name name-style="western"><surname>Dale</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Ford</surname><given-names>LT</given-names></string-name>, <string-name name-style="western"><surname>Street</surname><given-names>C</given-names></string-name>. <article-title>Are point&#8208;of&#8208;care urine drug testing devices suitable for antenatal drug screening? A study verifying the Alere&#174; drug screen test cup for the detection of six classes of drug in a pregnant population</article-title>. <source>Ann Clin Biochem</source>. <year>2021</year>;<volume>58</volume>:<fpage>166</fpage>&#8208;<lpage>173</lpage>.<pub-id pub-id-type="pmid">33435699</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0004563221990699</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="aogs14862-cit-0018"><string-name name-style="western"><surname>Harris</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Taylor</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Minor</surname><given-names>BL</given-names></string-name>, et&#160;al. <article-title>The REDCap consortium: building an international community of software platform partners</article-title>. <source>J Biomed Inform</source>. <year>2019</year>;<volume>95</volume>:<elocation-id>103208</elocation-id>.<pub-id pub-id-type="pmid">31078660</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jbi.2019.103208</pub-id><pub-id pub-id-type="pmcid">PMC7254481</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0018"><label>18</label><mixed-citation publication-type="miscellaneous" id="aogs14862-cit-0019"><article-title>Dansk Selskab for Klinisk Biokemi [Danish Society for Clinical Biochemistry]. Retningslinje for misbrugsanalysering for klinisk biokemiske laboratorier, version 2. 1 [Guidelines for substance abuse analysis for clinical biochemical laboratories, version 2.1.]</article-title>. <year>2020</year>.</mixed-citation></ref><ref id="aogs14862-bib-0019"><label>19</label><mixed-citation publication-type="miscellaneous" id="aogs14862-cit-0020"><article-title>Ferle ApS. Krydsreaktionsliste [Cross&#8208;reaction list]</article-title>.</mixed-citation></ref><ref id="aogs14862-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="aogs14862-cit-0021"><string-name name-style="western"><surname>Rausgaard</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Ibsen</surname><given-names>IO</given-names></string-name>, <string-name name-style="western"><surname>J&#248;rgensen</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Lamont</surname><given-names>RF</given-names></string-name>, <string-name name-style="western"><surname>Ravn</surname><given-names>P</given-names></string-name>. <article-title>Prevalence of substance abuse in pregnancy among Danish women</article-title>. <source>Acta Obstet Gynecol Scand</source>. <year>2015</year>;<volume>94</volume>:<fpage>215</fpage>&#8208;<lpage>219</lpage>.<pub-id pub-id-type="pmid">25366294</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/aogs.12528</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="aogs14862-cit-0022"><string-name name-style="western"><surname>Rausgaard</surname><given-names>NLK</given-names></string-name>, <string-name name-style="western"><surname>Broe</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bliddal</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Use of opioids among pregnant women 1997&#8208;2016: a Danish drug utilization study</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source>. <year>2023</year>;<volume>289</volume>:<fpage>163</fpage>&#8208;<lpage>172</lpage>.<pub-id pub-id-type="pmid">37683461</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejogrb.2023.08.375</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="aogs14862-cit-0023"><string-name name-style="western"><surname>Oga</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Mark</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Coleman&#8208;Cowger</surname><given-names>VH</given-names></string-name>. <article-title>Cigarette smoking status and substance use in pregnancy</article-title>. <source>Matern Child Health J</source>. <year>2018</year>;<volume>22</volume>:<fpage>1477</fpage>&#8208;<lpage>1483</lpage>.<pub-id pub-id-type="pmid">29882032</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10995-018-2543-9</pub-id><pub-id pub-id-type="pmcid">PMC6430977</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="aogs14862-cit-0024"><string-name name-style="western"><surname>Gonz&#225;lez&#8208;Colmenero</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Concheiro&#8208;Guis&#225;n</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Lorenzo&#8208;Mart&#237;nez</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Drug testing in biological samples vs. maternal surveys for the detection of substance use during whole pregnancy</article-title>. <source>J Addict Dis</source>. <year>2021</year>;<volume>39</volume>:<fpage>175</fpage>&#8208;<lpage>182</lpage>.<pub-id pub-id-type="pmid">33043834</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10550887.2020.1831137</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="aogs14862-cit-0025"><string-name name-style="western"><surname>Coleman&#8208;Cowger</surname><given-names>VH</given-names></string-name>, <string-name name-style="western"><surname>Oga</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Peters</surname><given-names>EN</given-names></string-name>, <string-name name-style="western"><surname>Trocin</surname><given-names>KE</given-names></string-name>, <string-name name-style="western"><surname>Koszowski</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Mark</surname><given-names>K</given-names></string-name>. <article-title>Accuracy of three screening tools for prenatal substance use</article-title>. <source>Obstet Gynecol</source>. <year>2019</year>;<volume>133</volume>:<fpage>952</fpage>&#8208;<lpage>961</lpage>.<pub-id pub-id-type="pmid">30969217</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/AOG.0000000000003230</pub-id><pub-id pub-id-type="pmcid">PMC6485306</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="aogs14862-cit-0026"><string-name name-style="western"><surname>Klawans</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Northrup</surname><given-names>TF</given-names></string-name>, <string-name name-style="western"><surname>Villarreal</surname><given-names>YR</given-names></string-name>, et&#160;al. <article-title>A comparison of common practices for identifying substance use during pregnancy in obstetric clinics</article-title>. <source>Birth</source>. <year>2019</year>;<volume>46</volume>:<fpage>663</fpage>&#8208;<lpage>669</lpage>.<pub-id pub-id-type="pmid">30916432</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/birt.12426</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="aogs14862-cit-0027"><string-name name-style="western"><surname>Iversen</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>S&#248;rensen</surname><given-names>NO</given-names></string-name>, <string-name name-style="western"><surname>Broberg</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Alcohol consumption and binge drinking in early pregnancy. A cross&#8208;sectional study with data from the Copenhagen pregnancy cohort</article-title>. <source>BMC Pregnancy Childbirth</source>. <year>2015</year>;<volume>15</volume>:<fpage>327</fpage>.<pub-id pub-id-type="pmid">26645438</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12884-015-0757-z</pub-id><pub-id pub-id-type="pmcid">PMC4673744</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="aogs14862-cit-0028"><string-name name-style="western"><surname>Persson</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Lindmark</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Petersson</surname><given-names>K</given-names></string-name>, et&#160;al. <article-title>Alcohol and illicit and non&#8208;medical prescription drug use before and during pregnancy in Stockholm, Sweden: a cross&#8208;sectional study</article-title>. <source>Sex Reprod Healthc</source>. <year>2021</year>;<volume>29</volume>:<elocation-id>100622</elocation-id>.<pub-id pub-id-type="pmid">34010729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.srhc.2021.100622</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="aogs14862-cit-0029"><string-name name-style="western"><surname>Jolma</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Koivu&#8208;Jolma</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Niemel&#228;</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Autti&#8208;R&#228;m&#246;</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Kahila</surname><given-names>H</given-names></string-name>. <article-title>Rapid urine screening for ethyl glucuronide from pregnant women as a tool for detecting prenatal alcohol exposure</article-title>. <source>BMC Pregnancy Childbirth</source>. <year>2023</year>;<volume>23</volume>:<fpage>464</fpage>.<pub-id pub-id-type="pmid">37349673</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12884-023-05789-x</pub-id><pub-id pub-id-type="pmcid">PMC10288688</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="aogs14862-cit-0030"><string-name name-style="western"><surname>Mercurio</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Politi</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Mezzetti</surname><given-names>E</given-names></string-name>, et&#160;al. <article-title>Ethyl glucuronide and ethyl sulphate in urine: caution in their use as markers of recent alcohol use</article-title>. <source>Alcohol Alcohol</source>. <year>2021</year>;<volume>56</volume>:<fpage>201</fpage>&#8208;<lpage>209</lpage>.<pub-id pub-id-type="pmid">33170266</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/alcalc/agaa113</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="aogs14862-cit-0031"><string-name name-style="western"><surname>Corbett</surname><given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Carmody</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Rochford</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Cunningham</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Lindow</surname><given-names>SW</given-names></string-name>, <string-name name-style="western"><surname>O'Connell</surname><given-names>MP</given-names></string-name>. <article-title>Drug use in pregnancy in Ireland's capital city: a decade of trends and outcomes</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source>. <year>2023</year>;<volume>282</volume>:<fpage>24</fpage>&#8208;<lpage>30</lpage>.<pub-id pub-id-type="pmid">36621262</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejogrb.2022.12.021</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="aogs14862-cit-0032"><string-name name-style="western"><surname>Saxov</surname><given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Pristed</surname><given-names>SG</given-names></string-name>, <string-name name-style="western"><surname>Kesmodel</surname><given-names>US</given-names></string-name>. <article-title>Characteristic associated with alcohol drinking in early pregnancy: a cross sectional study</article-title>. <source>Sci Rep</source>. <year>2023</year>;<volume>13</volume>:<fpage>10925</fpage>.<pub-id pub-id-type="pmid">37407640</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-023-38055-3</pub-id><pub-id pub-id-type="pmcid">PMC10322998</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="aogs14862-cit-0033"><string-name name-style="western"><surname>Praestegaard</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Kesmodel</surname><given-names>PS</given-names></string-name>, <string-name name-style="western"><surname>Kesmodel</surname><given-names>US</given-names></string-name>. <article-title>Is TWEAK a valid screening questionnaire to identify alcohol risk drinkers among pregnant women in Denmark?</article-title><source>Acta Obstet Gynecol Scand</source>. <year>2018</year>;<volume>97</volume>:<fpage>483</fpage>&#8208;<lpage>490</lpage>.<pub-id pub-id-type="pmid">29383707</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/aogs.13314</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="aogs14862-cit-0034"><string-name name-style="western"><surname>Board</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>D'Angelo</surname><given-names>DV</given-names></string-name>, <string-name name-style="western"><surname>Salvesen von Essen</surname><given-names>B</given-names></string-name>, et&#160;al. <article-title>Polysubstance use during pregnancy: the importance of screening, patient education, and integrating a harm reduction perspective</article-title>. <source>Drug Alcohol Depend</source>. <year>2023</year>;<volume>247</volume>:<elocation-id>109872</elocation-id>.<pub-id pub-id-type="pmid">37182339</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2023.109872</pub-id><pub-id pub-id-type="pmcid">PMC10332334</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="aogs14862-cit-0035"><string-name name-style="western"><surname>Kanervo</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Tupola</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Nikkola</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Rantakari</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Kahila</surname><given-names>HK</given-names></string-name>. <article-title>Buprenorphine&#8208;naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder</article-title>. <source>Acta Obstet Gynecol Scand</source>. <year>2023</year>;<volume>102</volume>:<fpage>313</fpage>&#8208;<lpage>322</lpage>.<pub-id pub-id-type="pmid">36562462</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/aogs.14497</pub-id><pub-id pub-id-type="pmcid">PMC9951318</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0035"><label>35</label><mixed-citation publication-type="miscellaneous" id="aogs14862-cit-0036"><article-title>Danmarks Statistik [Statistics Denmark]. Fertilitet 2021 [Fertility 2021]</article-title>.</mixed-citation></ref><ref id="aogs14862-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="aogs14862-cit-0037"><string-name name-style="western"><surname>Rausgaard</surname><given-names>NLK</given-names></string-name>, <string-name name-style="western"><surname>Ravn</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Ibsen</surname><given-names>IO</given-names></string-name>, <string-name name-style="western"><surname>Fruekilde</surname><given-names>PBN</given-names></string-name>, <string-name name-style="western"><surname>Nohr</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Damkier</surname><given-names>P</given-names></string-name>. <article-title>Clinical usefulness of a urine dipstick to detect ethyl glucuronide (EtG): a quantitative clinical study in healthy young female volunteers</article-title>. <source>Basic Clin Pharmacol Toxicol</source>. <year>2021</year>;<volume>128</volume>:<fpage>709</fpage>&#8208;<lpage>715</lpage>.<pub-id pub-id-type="pmid">33438372</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/bcpt.13558</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="aogs14862-cit-0038"><string-name name-style="western"><surname>Hasken</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Marais</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>de Vries</surname><given-names>MM</given-names></string-name>, et&#160;al. <article-title>Assessing the sensitivity and specificity of phosphatidylethanol (PEth) cutoffs to identify alcohol exposed pregnancies</article-title>. <source>Curr Res Toxicol</source>. <year>2023</year>;<volume>4</volume>:<elocation-id>100105</elocation-id>.<pub-id pub-id-type="pmid">37102125</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.crtox.2023.100105</pub-id><pub-id pub-id-type="pmcid">PMC10123138</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="aogs14862-cit-0039"><string-name name-style="western"><surname>Lange</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Shield</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Koren</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Rehm</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Popova</surname><given-names>S</given-names></string-name>. <article-title>A comparison of the prevalence of prenatal alcohol exposure obtained via maternal self&#8208;reports versus meconium testing: a systematic literature review and meta&#8208;analysis</article-title>. <source>BMC Pregnancy Childbirth</source>. <year>2014</year>;<volume>14</volume>:<fpage>127</fpage>.<pub-id pub-id-type="pmid">24708684</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2393-14-127</pub-id><pub-id pub-id-type="pmcid">PMC3992148</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="aogs14862-cit-0040"><string-name name-style="western"><surname>Skelton</surname><given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Donahue</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Benjamin&#8208;Neelon</surname><given-names>SE</given-names></string-name>. <article-title>Validity of self&#8208;report measures of cannabis use compared to biological samples among women of reproductive age: a scoping review</article-title>. <source>BMC Pregnancy Childbirth</source>. <year>2022</year>;<volume>22</volume>:<fpage>344</fpage>.<pub-id pub-id-type="pmid">35448967</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12884-022-04677-0</pub-id><pub-id pub-id-type="pmcid">PMC9027056</pub-id></mixed-citation></ref><ref id="aogs14862-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="aogs14862-cit-0041"><string-name name-style="western"><surname>Murnan</surname><given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Keim</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Klebanoff</surname><given-names>MA</given-names></string-name>. <article-title>Exploration of differences between women who do and do not disclose their marijuana use during pregnancy</article-title>. <source>Am J Perinatol</source>. <year>2022</year>;<volume>41</volume>:<fpage>902</fpage>&#8208;<lpage>908</lpage>.<pub-id pub-id-type="pmid">35240705</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/a-1787-6889</pub-id><pub-id pub-id-type="pmcid">PMC10008515</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>